Skip to main content
Clinical Trials/NCT04986553
NCT04986553
Withdrawn
N/A

A Multi-Center, Prospective Registry to Evaluate the Continued Safety and Performance of Clavicle Plates

Arthrex, Inc.2 sites in 1 countryMay 20, 2021

Overview

Phase
N/A
Intervention
Not specified
Conditions
Clavicle Fracture
Sponsor
Arthrex, Inc.
Locations
2
Primary Endpoint
To assess a change in Veterans Rand 12-Item Health Survey (VR-12)
Status
Withdrawn
Last Updated
2 years ago

Overview

Brief Summary

The objective of the registry is to evaluate the continued safety and performance of Arthrex Clavicle Plates used to treat clavicle fractures.

Detailed Description

To assess safety, device-related adverse events will be reported and evaluated over the course of the study. To evaluate the performance imaging of the target area will be evaluated at three months postoperative. Additionally, patient-reported outcomes will be evaluated at three months postoperative, 6 months postoperative, and one year postoperative using the Visual Analogue Scale (VAS), Veterans Rand 12-Item Health Survey (VR-12), and American Shoulder and Elbow Surgeons Standardized Shoulder Assessment Form (ASES).

Registry
clinicaltrials.gov
Start Date
May 20, 2021
End Date
July 30, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • The subject requires surgery using the Arthrex Clavicle Plate for clavicle fracture.
  • The subject is 18 years of age or over.
  • The subject is not considered a vulnerable subject (i.e., child, pregnant, nursing, prisoner, or ward of the state).
  • Subject signed informed consent and is willing and able to comply with all study requirements

Exclusion Criteria

  • Insufficient quantity or quality of bone.
  • Blood supply limitations and previous infections, which may retard healing.
  • Foreign-body sensitivity.
  • Any active infection or blood supply limitations.
  • Conditions that tend to limit the patient's ability or willingness to restrict activities or follow directions during the healing period.
  • Subjects that are skeletally immature.

Outcomes

Primary Outcomes

To assess a change in Veterans Rand 12-Item Health Survey (VR-12)

Time Frame: Preoperatively, 3 months, 6 months and 12 months postoperatively

Patient reported changes in general health and mental survey. Average score is 50 (negative answers bring scores down, positive answers bring scores up

To assess a change in American Shoulder and Elbow Surgeons Standardized Shoulder Assessment Form (ASES)

Time Frame: Preoperatively, 3 months, 6 months and 12 months postoperatively

ASES is a 100-point scale that consists of two dimensions: pain and activities of daily living. There is one pain scale worth 50 points and ten activities of daily living worth 50 points.

To assess a change in Visual Analogue Scale (VAS) survey

Time Frame: Preoperatively, 3 months, 6 months and 12 months postoperatively

Patient reported pain scale 0-10 point scale (0 min,10 max)

Study Sites (2)

Loading locations...

Similar Trials